Burning Rock Biotech (BNR) Short-term Investments (2021 - 2023)

Burning Rock Biotech has reported Short-term Investments over the past 3 years, most recently at $16666.5 for Q4 2023.

  • Quarterly results put Short-term Investments at $16666.5 for Q4 2023, down 99.4% from a year ago — trailing twelve months through Dec 2023 was $16666.5 (down 99.4% YoY), and the annual figure for FY2023 was $17000.0, down 99.42%.
  • Short-term Investments for Q4 2023 was $16666.5 at Burning Rock Biotech, down from $2.8 million in the prior quarter.
  • Over the last five years, Short-term Investments for BNR hit a ceiling of $2.8 million in Q4 2022 and a floor of $16666.5 in Q4 2023.
  • Median Short-term Investments over the past 3 years was $1.2 million (2021), compared with a mean of $1.3 million.
  • Biggest five-year swings in Short-term Investments: surged 128.54% in 2022 and later crashed 99.4% in 2023.
  • Burning Rock Biotech's Short-term Investments stood at $1.2 million in 2021, then surged by 128.54% to $2.8 million in 2022, then crashed by 99.4% to $16666.5 in 2023.
  • The last three reported values for Short-term Investments were $16666.5 (Q4 2023), $2.8 million (Q4 2022), and $1.2 million (Q4 2021) per Business Quant data.